Subramanian Krishnakumar Selected Research

Retinoblastoma (Glioblastoma, Retinal)

8/2022	Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis.
10/2020	Serum exosomal miRNA as biomarkers for Retinoblastoma.
1/2020	Clinical relevance of B7H3 expression in retinoblastoma.
2/2019	Synthesis of saporin-antibody conjugates for targeting EpCAM positive tumour cells.
9/2018	Targeting HMGA protein inhibits retinoblastoma cell proliferation.
9/2018	Atypical Presentation of Bilateral Retinoblastoma with Floaters and Sub-Internal Limiting Membrane Seeds in an 11-Year-Old Asian Indian Male.
6/2018	Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases.
12/2017	Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma.
1/2017	Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
10/2016	Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Subramanian Krishnakumar Research Topics

Disease

85	Neoplasms (Cancer) 02/2022 - 07/2003
67	Retinoblastoma (Glioblastoma, Retinal) 08/2022 - 03/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2003
10	Melanoma (Melanoma, Malignant) 03/2021 - 08/2003
8	Carcinogenesis 08/2016 - 06/2007
8	Uveal melanoma 01/2016 - 08/2003
5	Breast Neoplasms (Breast Cancer) 02/2019 - 01/2013
4	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022 - 02/2003
4	Carcinoma (Carcinomatosis) 02/2022 - 07/2003
3	Retinal Detachment (Retinal Detachments) 07/2021 - 11/2008
2	Cataract (Cataracts) 07/2021 - 01/2019
2	Lymphoma (Lymphomas) 07/2021 - 01/2013
2	Circulating Neoplastic Cells 07/2017 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2016 - 04/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 10/2009
2	Monosomy 01/2016 - 10/2009
2	Colonic Neoplasms (Colon Cancer) 01/2015 - 01/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2005 - 09/2003
2	Carcinoma in Situ 04/2005 - 09/2003
2	Disease Progression 04/2005 - 09/2003
1	Lacrimal Duct Obstruction 08/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Atrophy 07/2021
1	Anterior Uveitis 07/2021
1	Embryonal Rhabdomyosarcoma 12/2020
1	Scleritis (Episcleritis) 09/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2019
1	Brain Neoplasms (Brain Tumor) 09/2018
1	Geographic Atrophy 03/2017
1	Retinal Diseases 01/2017

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 08/2022 - 02/2003
19	Epithelial Cell Adhesion MoleculeIBA 11/2020 - 12/2004
13	MicroRNAs (MicroRNA)IBA 10/2020 - 10/2009
10	SurvivinIBA 10/2016 - 10/2013
9	Pharmaceutical PreparationsIBA 01/2017 - 01/2011
8	Small Interfering RNA (siRNA)IBA 11/2020 - 07/2011
8	Monoclonal AntibodiesIBA 01/2013 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 04/2010
7	Retinaldehyde (Retinal)IBA 01/2022 - 04/2010
7	ParaffinIBA 10/2009 - 06/2004
6	Biological ProductsIBA 01/2015 - 10/2009
6	CurcuminIBA 01/2015 - 10/2009
6	Histocompatibility Antigens Class IIBA 04/2005 - 08/2003
5	LigandsIBA 01/2017 - 03/2007
5	EnzymesIBA 01/2016 - 07/2003
5	Histocompatibility Antigens Class IIIBA 03/2004 - 08/2003
4	Peptides (Polypeptides)IBA 12/2017 - 09/2003
4	NucleolinIBA 07/2017 - 04/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2009
4	LipidsIBA 08/2016 - 01/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 08/2006 - 09/2003
3	Phosphotransferases (Kinase)IBA 06/2018 - 05/2010
3	GoldIBA 12/2017 - 01/2013
3	locked nucleic acidIBA 07/2017 - 09/2015
3	Messenger RNA (mRNA)IBA 10/2016 - 11/2015
3	CytokinesIBA 08/2016 - 01/2012
3	APTIBA 08/2016 - 02/2015
3	Phosphatidylcholines (Phosphatidylcholine)IBA 08/2016 - 09/2013
3	Carrier Proteins (Binding Protein)IBA 01/2016 - 12/2003
3	StathminIBA 12/2015 - 07/2011
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2015 - 01/2013
3	AntagomirsIBA 02/2015 - 01/2014
3	multidrug resistance-associated protein 1IBA 01/2015 - 04/2007
3	CalnexinIBA 03/2004 - 09/2003
3	tapasinIBA 03/2004 - 09/2003
3	Histocompatibility Antigens (Histocompatibility Antigen)IBA 03/2004 - 09/2003
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 06/2007
2	ZinostatinIBA 01/2017 - 01/2016
2	Nucleotide AptamersIBA 01/2016 - 01/2012
2	AntioxidantsIBA 01/2016 - 09/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 09/2012
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2011
2	Vincristine (Oncovin)FDA LinkGeneric 01/2015 - 07/2011
2	CeruleninIBA 01/2013 - 06/2012
2	Complementary DNA (cDNA)IBA 01/2013 - 01/2013
2	Mitogen-Activated Protein KinasesIBA 01/2012 - 05/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2011 - 01/2011
2	Formaldehyde (Formol)FDA Link 10/2009 - 06/2004
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Periodic AcidIBA 10/2021
1	Rituximab (Mabthera)FDA Link 07/2021
1	Immunoglobulin G (IgG)IBA 09/2020
1	SaporinsIBA 02/2019
1	PolymersIBA 01/2019
1	HMGA ProteinsIBA 09/2018
1	Sirtuin 1IBA 06/2018
1	Histones (Histone)IBA 06/2018
1	OligonucleotidesIBA 01/2017
1	Propidium (Propidium Iodide)IBA 01/2017
1	N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA 01/2017

Therapy/Procedure

22	Therapeutics 01/2020 - 12/2004
12	Drug Therapy (Chemotherapy) 12/2020 - 12/2003
4	Radiotherapy 03/2021 - 12/2003
2	Immunotherapy 01/2020 - 01/2012
1	Dacryocystorhinostomy 08/2022
1	Cryotherapy (Therapy, Cold) 02/2022
1	Endotamponade 01/2019
1	Vitrectomy 01/2019
1	Combined Modality Therapy 09/2018
1	Adjuvant Chemotherapy 01/2017